시장보고서
상품코드
1179903

세계의 호흡 모니터링 기기 시장(2023-2030년)

Global Respiratory Monitoring Devices Market - 2023-2030

발행일: | 리서치사: DataM Intelligence | 페이지 정보: 영문 200 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 호흡 모니터링 기기 시장 규모는 예측기간(2023-2030년)에 CAGR 9.3%로 성장할 것으로 예측됩니다.

목차

제1장 조사 방법과 조사 범위

  • 조사 방법
  • 조사 목적 및 조사 범위

제2장 시장 정의와 개요

제3장 주요 요약

제4장 시장 역학

  • 시장 영향요인
    • 성장 촉진요인
    • 성장 억제요인
    • 비지니스 기회
    • 영향 분석

제5장 산업 분석

  • Porter's Five Forces 분석
  • 공급망 분석
  • 규제 분석

제6장 COVID-19의 분석

  • COVID-19의 시장 분석
    • COVID-19 이전 시장 시나리오
    • COVID-19 현재 시장 시나리오
    • COVID-19 이후 또는 향후 시나리오
  • COVID-19 중에서의 가격 역학
  • 수요-공급 스펙트럼
  • 팬데믹 동안 시장과 관련된 정부 대처
  • 제조업체의 전략적 대처
  • 정리

제7장 제품별

  • 폐활량계
  • 최대호기량측정기
  • 수면 검사 기기
  • 가스 분석기
  • 산소포화도측정기
  • 카프노그래피

제8장 최종사용자별

  • 병원
  • 진단 실험실
  • 재택의료

제9장 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 남미
    • 브라질
    • 아르헨티나
    • 기타 남미
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카

제10장 경쟁 상황

  • 주요 전개와 전략
  • 기업 점유율 분석
  • 제품 벤치마크

제11장 기업 개요

  • Medtronics Plc
    • 기업 개요
    • 제품 포트폴리오와 설명
    • 주요 하이라이트
    • 재무 개요
  • GE Healthcare
  • SMITH & NEPHEW
  • VYAIRE(CAREFUSION CORPORATION)
  • Masimo Corporation
  • MGC Diagnostics Corporation
  • COSMED
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Smith's Medical

제12장 DataM

KSM 23.01.19

Market Overview

The global respiratory monitoring devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 9.3% during the forecast period (2023-2030).

Respiratory monitoring devices are employed to diagnose or monitor acute or chronic respiratory disorders by specifying the respiratory capacities of the lungs. Several respiratory tests are being developed to monitor the efficiency of the lungs in exchanging respiratory gases and identify obstructions in the respiratory tract.

Market Dynamics

The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.

The increasing cases of respiratory diseases and market developments are anticipated to propel the respiratory monitoring devices market growth.

The rising air pollution and bad lifestyle choices are inducing an advancement in global respiratory cases, expanding the growth of respiratory monitoring devices. For instance, the United Nations Environment Program reports that air pollution is the most powerful global environmental threat to public fitness, accounting for an estimated 7 million early deaths annually. Moreover, according to the WHO, tobacco consumption leads to over 8 million deaths yearly, of which 7 million are from active usage and about 1.2 million are from passive smoke.

Also, the market events are propelling the global respiratory monitoring devices market growth. For instance, in July 2022, Switzerland-based medical technology company Sleepiz enlisted its Sleepiz One + contactless respiration and heart rate monitoring device with the US Food and Drug Administration (FDA). The FDA listing forms the way for Sleepiz to deliver its solution for remote patient monitoring in the US. Therefore, the above data indicate that the rising cases of respiratory disorders and product launches are pushing the global respiratory monitoring devices market during the forecast period.

The high cost is expected to hinder global respiratory monitoring devices market growth.

However, the high cost of respiratory monitoring devices hinders the growth of global respiratory monitoring devices in the forecast period. For instance, the average price of a spirometer ranges from $900-$3000. Nevertheless, there is an extensive deviation in price based on the type of spirometer.

COVID-19 Impact.

COVID-19 has greatly impacted the global respiratory monitoring devices market as coronavirus disease (COVID-19), infection of the SARS-CoV-2 virus predominantly to the lungs. A large number of the infected individuals encountered temperate to moderate respiratory trouble. Since a large population across the globe was infected with COVID-19, this led to overall elevated sales of respiratory monitoring devices such as spirometers, oximeters, peak flow meters, Etc. Furthermore, COVID-19 encouraged new developments and innovations in respiratory monitoring devices, positively influencing the global Respiratory Monitoring Devices market.

Segment Analysis

The spirometer segment is expected to grow at the fastest CAGR during the forecast period (2022-2029).

Spirometers are estimated to grow at a high CAGR throughout the forecast period (2022-2029). A spirometer is a device for estimating air volume inspired and exhaled by the lungs. A spirometer estimates ventilation, the motion of air into and out of the lungs. The spirogram obtained from the spirometer will determine the presence or absence of two abnormal ventilation patterns, obstructive and restrictive. The new product launches are expected to boost the growth of the spirometer segment in the forecast period. For instance, in March 2020, the FDA issued an Umbrella Emergency Use Authorization in response to the insufficient reserve and availability of FDA-approved spirometers for use in healthcare settings in treating patients during the COVID-19 pandemic.

Moreover, in March 2021, Vyaire Medical introduced its inventive remote Aiocare mobile spirometer in the UK. Also, in August 2022, AstraZeneca India formed a partnership with Alveofit to offer IoT-enabled handheld spirometers at hospitals around the country. Likewise, in November 2021, Cipla Limited launched its Spirofy, one of the first pneumotach-based portable, wireless spirometers in India, on the day of world pulmonary diseases. Thus, the earlier data indicates that ventilators and resuscitators are expected to dominate the global respiratory device market during the forecast period (2022-2029).

Geographical Analysis

The North American region holds the largest market share of the global respiratory monitoring devices market.

North America holds most of the global respiratory monitoring devices market share. It is anticipated to dominate during the forecasted period (2022-2029). The American population is at a rising threat of respiratory conditions because of growing air pollution and lifestyle choices. For instance, according to the USEPA, roughly 67 million tons of pollution were ejected into the United States in 2021. Moreover, the American Lung Association State of the Air 2022 report reveals that despite decades of progress in cleansing up the air pollution sources, above 40% of Americans, i.e., 137 million, are living in zones with growing rates of harmful particle pollution which has increased by 2.1 million American than the last year's reported number. Additionally, the rising tobacco use in America ensures this region's dominance over the global market. According to the CDC, an assessed 12.5% of U.S. adults smoked cigarettes in 2020, and as to the National Youth Tobacco Survey (NYTS) by the FDA and CDC, across 2.5 million U.S. middle and high school students presently used e-cigarettes in 2022.

Similarly, the market developments by North America-based key players assure this region's dominance over the global respiratory monitoring device market. For example, in January 2020, Masimo Corporation obtained NantHealth, Inc. In May 2021, Vyaire Medical cooperated with GenWorks, a healthcare solutions provider in 140 locations in India. Thus, with the data mentioned above, it is indicated that North America will dominate the global respiratory monitoring device market in the projected period.

Competitive Landscape

The essential players functioning in the global respiratory monitoring devices market are GE Healthcare, Smith & Nephew, Vyaire (Carefusion Corporation), Masimo Corporation, Medtronic plc, MGC Diagnostics Corporation, COSMED, Nihon Kohden Corporation, Philips Healthcare and many more. The key players are embracing various approaches such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the Respiratory Monitoring Devices market growth. For instance, In March 2020, Medtronic announced the expansion of remote respiratory monitoring solutions to fight against COVID-19.

Medtronic plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronic deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

Medtronic plc's product portfolio for respiratory monitoring devices has Nellcor pulse oximetry: The Nellcor pulse oximetry system with OxiMax technology establishes a new milestone in patient safety monitoring that can impact clinical settings from everyday to the extraordinary.

The global respiratory monitoring devices market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Cases of Pulmonary Diseases
      • 4.1.1.2. Research and Development
      • 4.1.1.3. Market Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Spirometer
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Peak Flow Meters
  • 7.4. Sleep Test Devices
  • 7.5. Gas Analyzers
  • 7.6. Pulse Oximeters
  • 7.7. Capnography

8. By End user

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 8.1.2. Market Attractiveness Index, By End user
  • 8.2. Hospitals
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Diagnostic Laboratories
  • 8.4. Homecare

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Company Profiles

  • 11.1. Medtronics Plc
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. GE Healthcare
  • 11.3. SMITH & NEPHEW
  • 11.4. VYAIRE (CAREFUSION CORPORATION)
  • 11.5. Masimo Corporation
  • 11.6. MGC Diagnostics Corporation
  • 11.7. COSMED
  • 11.8. Nihon Kohden Corporation
  • 11.9. Philips Healthcare
  • 11.10. Smith's Medical

LIST NOT EXHAUSTIVE

12. DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제